Investors in Ar

In a nutshell, Commercialization Reactor is a platform with a mission to commercialize science via a specific paradigm: Bring Scientists and Entrepreneurs together to co-create Deep-Tech startup aimed to commercialize the Core Competence of the Scientific Team. The Entrepreneurs become responsible to fulfill business leadership-related activities, taking into a full-time focus and Scientists focus exclusively on their core competence and inhale their knowledge and skills into a product or service that Entrepreneurial Team sets as a vector for business development strategy. This paradigm of commercialization together with over 10 years of experience in creating, pre-incubating and accelerating startups currently resulted in over 100 fully-formed Science-based startup companies born in CR. Most of those received investments are from various venture funds across the globe. Ultimately, this leads to unique Science-based startup creation and performance scoring methodology that is a core know-how of Commercialization Reactor. The methodology is proven successful by a fact of an exit, which already is in the arsenal of achievements of the CR Team.

Index Ventures partners with exceptional entrepreneurs – those with unique insight who are intrinsically driven to make their vision a reality. We help them turn their bold ideas into global businesses, and through the companies they build, have a long-lasting and positive impact on the world around us. Index-backed businesses are supported by an experienced team of investors, strategists, and an extensive global network built over three decades of startup investing. Working side-by-side through the scale up journey, we forge deep and long-lasting relationships with founders and their teams. The vast majority of these partnerships begin early in the company’s life, at Seed and Series A, and extend to IPO and beyond. Operating as one team, with feet firmly on both sides of the Atlantic – from London to Tel Aviv, and San Francisco to New York – we are an international team with a global mindset, with experience supporting founders wherever they emerge. When they succeed, they generate returns that in turn support Index’s investors, including non-profit foundations; education, healthcare and research endowments; and other impact-driven organizations.

ADP Invest is the Corporate Venture Capital ("CVC") fund of the Groupe ADP. It invests in start-ups and venture capital funds in line with the company's strategic priorities : Passenger Experience, Airport Operations & Infrastructure, Future of Work and Decarbonization. We focus on financing companies that have already experimented with the Groupe ADP, based on needs expressed by the company's various business divisions. Each investment is sponsored by one of these departments, and their representatives sit on our investment committee.

Scientipole Ile-de-France Capital is a French venture capital firm specialized in funding seed stage companies. Scientipôle Capital invests in the innovative tech-based startups, at early stage. Team keeps a close relationship during the entire investment period to help entrepreneurs to succeed in all areas of management Scientipôle Capital is focused on innovative technologies developed in the Paris-Saclay area: • Solutions for the industry 4.0 : digital technologies, industrial technologies • Green tech applications to support energy and ecological transitions - smart grid, smart city • Health / medtech (except drugs) ...

Kvanted is an early-stage venture capital fund investing in Northern European companies with industry-changing software and hardware solutions. Our investment philosophy is rooted in accelerating industrial decarbonization and digital transformation, driven by powerful tailwinds from increased demand for industrial automation, sustainability, and supply chain resilience. As the next Industrial Revolution introduces new growth possibilities through groundbreaking technologies, we recognize the innovation potential of traditional European industries.

The fund is primarily supported by institutional investors, including public bank Bpifrance and insurance companies MACSF, Sogécap, and Crédit Agricole Assurances. Varsity has collaborated with asset management firm Elevation Capital Partners to establish a feeder fund that will contribute to the VC's second closing.

The flagship initiative of the investment programmme will be the Circularity Fund, to which SHEIN will provide the launch capitalisation of €200 million. Building on SHEIN’s existing programs to advance R&D and innovation in circularity for the fashion industry, the Fund will support start-ups and businesses throughout Europe and the UK that are developing next-generation technologies and solutions by: Investing in early-stage start-ups working on textile-to-textile recycled materials innovation and related areas. Entering into offtake agreements or other commercial partnerships with more mature start-ups with existing production capacity in textile-to-textile recycled materials or new and emerging preferred fibres. SHEIN will be the cornerstone investor of the Circularity Fund and is inviting businesses, financial institutions, sovereign wealth funds globally to co-invest in the Fund.

The Merantix AI Fund builds and invests in category-defining early-stage AI-native companies, always seeking the largest exponential lever through AI as a general-purpose technology. We strongly believe in and focus on vertically integrated business models, data flywheel effects, multidisciplinary founding teams, societal impact, and leveraging the European industry sovereignty.

In March 2022 we closed our first $20m fund, to invest globally in early-stage companies innovating in consumer-internet.

The healthtech arm of IPQ Capital, the Family Office of Fryland Møller Pathiraja family. We invest in ambitious European healthtech companies at Seed and Series A. Our deep medical expertise, powerful network and agile approach enable founders to build important, world-class healthcare businesses.

We back growth-stage ventures in verticals including esports, e-commerce, biotech, artificial intelligence, robotics and technology hardware. We also make private market investments into companies with a clear path toward an imminent IPO.

Beringea is a transatlantic venture capital investor that seeks to create lasting success for rapidly scaling entrepreneurial companies. We provide patient and intelligent capital and a global footprint to back entrepreneurs throughout their journey. For U.K. and European entrepreneurs: We'll typically make an initial investment between £1-10 million into companies turning over approximately £1 million or more. We tend to lead Series A or Series B rounds, with further funding available for follow-on investments.